Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Innovax Holdings Limited (2680.HK)
Wan Chai, HK
Innovax Holdings Limited functions as an investment holding enterprise, delivering a comprehensive suite of financial and securities services throughout Hong Kong. The company's core offerings include corporate finance advisory, which encompasses initial public offering (IPO) sponsorship, general financial guidance, independent financial advisory, and regulatory compliance assistance. Innovax also facilitates securities transactions through its dealing and brokerage operations. Additionally, it provides securities financing, covering margin financing for secondary market purchases and IPO financing for subscriptions within public offering tranches. The firm's service portfolio extends to asset management, featuring fund and discretionary account management, alongside futures dealing and money lending. Innovax also plays a significant role in capital markets by acting as a placing or sub-placing agent for new share issuances by publicly listed companies, and as a global coordinator, bookrunner, lead manager, or underwriter for IPOs of aspiring listed entities. Established in 2014, Innovax Holdings Limited is headquartered in Wan Chai, Hong Kong, and operates as a subsidiary of Billion Shine International Investment Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.76% | -5.31% | -20.39% | -32.79% | -28.07% | -15.46% | +318.37% | +184.72% | +88.51% | +42.36% | +42.36% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Financial - Capital Markets: +19.7%+383.5% ★ Q3'25: +216.1% (vs Q3'23)
-
EPS growth Financial - Capital Markets: +35.3%-1,892.2% Q3'25: +25.0% (vs Q3'23)
-
FCF margin FCF growth · Financial - Capital Markets: +29.5%-33.0% Q3'25: +0.0% (vs Q3'23)
-
EBIT margin Financial - Capital Markets: +33.5%-22.3% Q3'25: +48.6% (vs Q3'23)
-
ROIC Financial - Capital Markets: +4.0%-75.2% Q3'25: +125.8% (vs Q3'23)
-
Share dilution Financial - Capital Markets: +0.0%+11.3% Q3'25: +50.0% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Financial - Capital Markets: -0.30×-0.04× Q3'25: 0.02× (vs Q3'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-26 | B | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 4/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 4/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 4/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-04 | B | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 5/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Siu Kuen Poon | Chief Executive Officer & Executive Director | 1M | male |
| Chi Man Chung | Executive Chairman | 1M | male |
| Alvin Kam | MD & Head of Corporate Finance | — | male |
| Lok Yi Chau | Chief Financial Officer & Company Secretary | — | female |
| Lok Yuen Chau | Head of Equity Capital Markets | — | female |
| Lap Sun Li | Chief Investment Officer | — | male |
| King Fung Lam | Chief Operating Officer and Head of Risk & Compliance | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2680.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
